{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230322",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "73827",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/217417Orig1s000ltr.pdf",
              "date": "20230323",
              "type": "Letter"
            },
            {
              "id": "73833",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217417s000lbl.pdf",
              "date": "20230323",
              "type": "Label"
            },
            {
              "id": "74014",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/217417Orig1s000TOC.html",
              "date": "20230418",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20251210",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "submission_property_type": [
            {
              "code": "Orphan"
            }
          ],
          "application_docs": [
            {
              "id": "84387",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/217417Orig1s008ltr.pdf",
              "date": "20251211",
              "type": "Letter"
            },
            {
              "id": "84443",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217417s008lbl.pdf",
              "date": "20251218",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA217417",
      "sponsor_name": "MUNDIPHARMA",
      "openfda": {
        "application_number": [
          "NDA217417"
        ],
        "brand_name": [
          "REZZAYO"
        ],
        "generic_name": [
          "REZAFUNGIN"
        ],
        "manufacturer_name": [
          "Melinta Therapeutics, LLC"
        ],
        "product_ndc": [
          "70842-240"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "REZAFUNGIN"
        ],
        "rxcui": [
          "2639160",
          "2639165"
        ],
        "spl_id": [
          "2b7bcdc0-0333-42a1-942c-7b2efeb2398a"
        ],
        "spl_set_id": [
          "90073508-6dca-4d27-aa5a-ed837737c35b"
        ],
        "package_ndc": [
          "70842-240-01"
        ],
        "nui": [
          "N0000175507",
          "M0519359"
        ],
        "pharm_class_epc": [
          "Echinocandin Antifungal [EPC]"
        ],
        "pharm_class_cs": [
          "Lipopeptides [CS]"
        ],
        "unii": [
          "G013B5478J"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "REZZAYO",
          "active_ingredients": [
            {
              "name": "REZAFUNGIN ACETATE",
              "strength": "EQ 200MG BASE/VIAL"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}